Article
Small molecule-induced ERBB4 activation to treat heart failure
2024-04-08
Abstract excerpt
<title>Abstract</title> <p>Heart failure is a common and deadly disease, requiring new therapeutic approaches. The neuregulin-1 (NRG1)/erythroblastic leukemia viral oncogene homolog 4 (ERBB4) pathway is an interesting target because of its cardioprotective effects. The therapeutic use of recombinant NRG1 has been difficult, because it requires intravenous administration and is non-selective for the ERBB4 receptor...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 620ab4d1-a7a8-572f-9c5a-f30be0c93f99
- DOI
- 10.21203/rs.3.rs-4175488/v1
